PCN9 CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV)—OUTCOMES OF PROPHYLACTIC CARE AND COSTS IN GERMAN CANCER CENTERS by Ehlken, B, Ihbe-Heffinger, A, Berger, K, Kugland, B, Lordick, F, Eichler, HG, Deuson, R, Thödtmann, J, Bernard, R

Get full text

1053 Indicators of high chemotherapy-induced nausea and vomiting treatment costs in German cancer centers by Ehlken, B., Lordick, F., Bernard, R., Berger, K., Heichler, H.G., Deuson, R., Thödtmann, J., Ihbe-Heffinger, A.

Get full text

A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer by Schippinger, W, Samonigg, H, Schaberl-Moser, R, Greil, R, Thödtmann, R, Tschmelitsch, J, Jagoditsch, M, Steger, G G, Jakesz, R, Herbst, F, Hofbauer, F, Rabl, H, Wohlmuth, P, Gnant, M, Thaler, J

Get full text

Preoperative treatment with capecitabine, cetuximab and radiotherapy for primary locally advanced rectal cancer--a phase II clinical trial by Eisterer, Wolfgang, De Vries, Alexander, Öfner, Dietmar, Rabl, Hans, Koplmüller, Renate, Greil, Richard, Tschmelitsch, Jöerg, Schmid, Rainer, Kapp, Karin, Lukas, Peter, Sedlmayer, Felix, Höfler, Gerald, Gnant, Michael, Thaler, Josef

Get full text

A phase II trial of pemetrexed in patients with metastatic renal cancer by THÖDTMANN, R, SAUTER, T, WEINKNECHT, S, WEISSBACH, L, BLATTER, J, OHNMACHT, U, HANAUSKE, A.-R

Get full text

An EORTC-ECSG phase I study of LU 79553 administered every 21 or 42 days in patients with solid tumours by Awada, A, Thödtmann, R, Piccart, M.J, Wanders, J, Schrijvers, A.H.G.J, Von Broen, I.-M, Hanauske, A.R

Get full text

Preoperative Oxaliplatin, Capecitabine, and External Beam Radiotherapy in Patients with Newly Diagnosed, Primary Operable, cT3NxM0, Low Rectal Cancer: A Phase II Study by Öfner, Dietmar, DeVries, Alexander F., Schaberl-Moser, Renate, Greil, Richard, Rabl, Hans, Tschmelitsch, Jörg, Zitt, Matthias, Kapp, Karin S., Fastner, Gerd, Keil, Felix, Eisterer, Wolfgang, Jäger, Robert, Offner, Felix, Gnant, Michael, Thaler, Josef

Get full text

Phase I and pharmacokinetic study of CHOP/MGBG(CM) in patients with Non-Hodgkln's-Lymphoma by Thödtmann, R., Smith, S., Römer, W., Depenbrock, H., Rizzo, J., Heinrich, B., Dietzfelbinger, H., Rastetter, J., von Hoff, D.D., Hanauske, A.-R.

Get full text

Clinical and pharmacoklnetic evaluation of the new blsnaphtalamlde LU 79553 administered every 21 days in patients with solid tumors: An EORTC/ECSG study by Thōdtmann, R., Awada, A., Piccart, M., Höppener, F., Wanders, J., von Broen, I.-M., Hanauske, A.-R.

Get full text